The staff of the Faculty of Medicine, UPJŠ contributed to the solution to infertility thanks to a patent, the preparation of which was primarily participated in by two faculty departments – the Department of Medical and Clinical Biochemistry UPJŠ FM and the Department of Gynecology and Obstetrics UPJŠ FM and L. Pasteur University Hospital in Košice.
The innovative diagnostic-predictive method was created based on wider cooperation between the institutions UPJŠ FM and Gyncare s.r.o. , Comenius University in Bratislava (Department of Microbiology and Virology, Faculty of Science) and Masaryk University in Brno (CEITEC). The patent under the title “MicroRNA test for the success of the in vitro fertilization (IVF) process and diagnostics of a quality embryo for the IVF process” also received the prestigious award “Innovation of Slovakia 2021” and it was purchased by the start-up FETUS, IVS a.s. belonging to the FABA Capital group at the end of last year. The interest of this company is the commercialization of the project in the treatment of infertility through IVF with the aim of reducing the number of unwanted abortions and increasing the chances of couples successfully delivering a child.
Several research activities for the successful creation of an innovative diagnostic-predictive method were carried out by the Department of Medical and Clinical Biochemistry, UPJŠ FM under the leadership of its Head, prof. Ing. Mária Mareková, CSc., while the key solution was the project VEGA 1/0620/19 under the leadership of the responsible researcher assoc. prof. RNDr. Miroslava Rabajdová, PhD. and the significant contribution of assoc. prof. Silvia Toporcerová, M.D., PhD., MPH, MBA.
Both originators are pleased with the success of the project, the creation of a patent, and the commercial interest in it, as its subsequent clinical verification can contribute to increasing the success of the in vitro fertilization process and increase the chance of becoming parents for many infertile couples.
